Greenbaum, C. J. et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 61, 2066–2073 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oram, R. A., Sims, E. K. & Evans-Molina, C. Beta cells in type 1 diabetes: mass and function; sleeping or dead? Diabetologia 62, 567–577 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powers, A. C. Type 1 diabetes mellitus: much progress, many opportunities. J. Clin. Invest. 131, e142242 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Carr, A. L. J. et al. Circulating C-peptide levels in living children and young people and pancreatic β-cell loss in pancreas donors across type 1 diabetes disease duration. Diabetes 71, 1591–1596 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatovic, D. & Dayan, C. M. Replacing insulin with immunotherapy: time for a paradigm change in type 1 diabetes. Diabet. Med. 38, e14696 (2021).

Article  PubMed  Google Scholar 

Mathieu, C., Martens, P. J. & Vangoitsenhoven, R. One hundred years of insulin therapy. Nat. Rev. Endocrinol. 17, 715–725 (2021).

Article  PubMed  Google Scholar 

Russell-Jones, D. & Herring, R. 100 years of physiology, discrimination and wonder. Diabet. Med. 38, e14642 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A. & Evans-Molina, C. 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat. Med. 27, 1154–1164 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller, K. M. et al. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care 38, 971–978 (2015).

Article  PubMed  Google Scholar 

McKnight, J. A. et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet. Med. 32, 1036–1050 (2015).

Article  CAS  PubMed  Google Scholar 

Wasag, D. R., Gregory, J. W., Dayan, C., Harvey, J. N. & Brecon, G. Excess all-cause mortality before age 30 in childhood onset type 1 diabetes: data from the Brecon Group Cohort in Wales. Arch. Dis. Child. 103, 44–48 (2018).

Article  PubMed  Google Scholar 

Foster, N. C. et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol. Ther. 21, 66–72 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderzen, J. et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence – a quality registry study. Pediatr. Diabetes 21, 621–627 (2020).

Article  CAS  PubMed  Google Scholar 

Prigge, R. et al. International comparison of glycaemic control in people with type 1 diabetes: an update and extension. Diabet. Med. 39, e14766 (2022).

Article  CAS  PubMed  Google Scholar 

Jones, A. G. & Hattersley, A. T. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet. Med. 30, 803–817 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatovic, D. et al. Diagnosing type 1 diabetes in adults: guidance from the UK T1D immunotherapy consortium. Diabet. Med. 39, e14862 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Food and Drug Administration. FDA approves first drug that can delay onset of type 1 diabetes. FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes (2022).

Couper, J. J. et al. ISPAD clinical practice consensus guidelines 2018: stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 19, 20–27 (2018).

Article  PubMed  Google Scholar 

American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes — 2021. Diabetes Care 44, S15–S33 (2021).

Article  Google Scholar 

Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473–2479 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964–1974 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cherubini, V. et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia 63, 1530–1541 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Ng, S. M. et al. Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey. BMJ Paediatr. Open 4, e000884 (2020).

Article  PubMed  Google Scholar 

Karges, B. et al. A comparison of familial and sporadic type 1 diabetes among young patients. Diabetes Care 44, 1116–1124 (2021).

Article  CAS  PubMed  Google Scholar 

Atkinson, M. A., Campbell-Thompson, M., Kusmartseva, I. & Kaestner, K. H. Organisation of the human pancreas in health and in diabetes. Diabetologia 63, 1966–1973 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Bingley, P. J. & Williams, A. J. Islet autoantibody testing: an end to the trials and tribulations? Diabetes 62, 4009–4011 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wyatt, R. & Williams, A. J. Islet autoantibody analysis: radioimmunoassays. Methods Mol. Biol. 1433, 57–83 (2016).

Article  CAS  PubMed  Google Scholar 

Lampasona, V. & Liberati, D. Islet autoantibodies. Curr. Diab Rep. 16, 53 (2016).

Article  PubMed  Google Scholar 

Williams, C. L. & Long, A. E. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes? Diabetologia 62, 1969–1976 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

So, M. et al. Advances in type 1 diabetes prediction using islet autoantibodies: beyond a simple count. Endocr. Rev. 42, 584–604 (2021).

Article  PubMed  Google Scholar 

Besser, R. E. J., Ng, S. M. & Robertson, E. J. Screening children for type 1 diabetes. BMJ 375, e067937 (2021).

Article  CAS  PubMed  Google Scholar 

Besser, R. E. J. et al. General population screening for childhood type 1 diabetes: is it time for a UK strategy? Arch. Dis. Child. 107, 790–795 (2022).

Article  PubMed  Google Scholar 

Sims, E. K. et al. Screening for type 1 diabetes in the general population: a status report and perspective. Diabetes 71, 610–623 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quinn, L. M. et al. EarLy surveillance for autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1). BMJ Open Diabetes Res. Care 10, e002750 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ziegler, A. G. et al. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA 323, 339–351 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diabetes Prevention Trial – Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346, 1685–1691 (2002).

Article  Google Scholar 

Mahon, J. L. et al. The TrialNet natural history study of the development of type 1 diabetes: objectives, design, and initial results. Pediatr. Diabetes 10, 97–104 (2009).

Article  PubMed  Google Scholar 

Gale, E. A., Bingley, P. J., Emmett, C. L. & Collier, T. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363, 925–931 (2004).

Article  CAS  PubMed  Google Scholar 

Malkani, S. & Kotwal, A. Frequency and predictors of self-reported hypoglycemia in insulin-treated diabetes. J. Diabetes Res. 2017, 7425925 (2017).

Article